The ROE as of September 2024 (TTM) for Axonics, Inc. (AXNX) is -0.27%

According to Axonics, Inc.’s latest financial reports and current stock price. The company's current ROE is -0.27%. This represents a change of 261.26% compared to the average of -0.08% of the last 4 quarters.

Axonics, Inc. (AXNX) Historical ROE (quarterly & annually)

How has AXNX ROE performed in the past?

The mean historical ROE of Axonics, Inc. over the last ten years is -6.39%. The current -0.27% ROE has changed -95.74% with respect to the historical average. Over the past ten years (40 quarters), AXNX's ROE was at its highest in in the June 2023 quarter at 40.07%. The ROE was at its lowest in in the March 2017 quarter at -47.45%.

Axonics, Inc. (AXNX) ROE by Quarter and Year

Discovering the peaks and valleys of Axonics, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Axonics, Inc. (AXNX) Average ROE

How has AXNX ROE performed in the past?

The current ROE of Axonics, Inc. (AXNX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Axonics, Inc. (AXNX) ROE vs. Peers

How is AXNX’s ROE compared to its peers?

Axonics, Inc.’s ROE is less than Orthofix Medical Inc. (0%), greater than NuVasive, Inc. (-20.68%), less than Glaukos Corporation (3.46%), greater than Heska Corporation (-30.87%), greater than Bruker Corporation (-3.24%), less than Integer Holdings Corporation (24.25%), less than CONMED Corporation (6.95%), less than LivaNova PLC (11.71%), greater than iRhythm Technologies, Inc. (-1.33%), greater than OrthoPediatrics Corp. (-84.98%), greater than Pulmonx Corporation (-6.73%), greater than SI-BONE, Inc. (-50.79%), greater than NeuroPace, Inc. (-24.27%), greater than Integra LifeSciences Holdings Corporation (-195.26%), less than Monogram Orthopaedics, Inc. (1.24%), greater than Nano-X Imaging Ltd. (-109.96%), greater than Medtronic plc (-30.34%), less than null (7.80%),

Build a custom stock screener for Axonics, Inc. (AXNX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Axonics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Axonics, Inc. (AXNX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Axonics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.